Marius Pharmaceuticals
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8601 Six Forks Rd Ste 630, Raleigh, Nort...Phone Number
(919) 374-1913Website
www.mariuspharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Marius Pharmaceuticals
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies aimed at improving metabolic vitality and well-being. The company focuses on addressing testosterone deficiency with innovative solutions for both men and women, particularly through their proprietary oral testosterone therapy, KYZATREX. This prescription treatment is designed for adult men with low or no testosterone levels due to specific medical conditions. Marius Pharmaceuticals is committed to ongoing research to explore the broader implications of testosterone therapy in various patient populations.Explore more
Marius Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Marius Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Marius Pharmaceuticals had a recent Job posting/layoffs
Marius Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Marius Pharmaceuticals
Funding: Get notified immidiatlly once Marius Pharmaceuticals has new funding data
Product Launch: Get notified when Marius Pharmaceuticals launches new products
Earning: See what the market has to say on Marius Pharmaceuticals recently announced quarterly report
Check out if Marius Pharmaceuticals is spiking on competitors!
Check if Marius Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Marius Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Marius Pharmaceuticals
Compare insights from companies similar to Marius Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Marius Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Marius Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Marius Pharmaceuticals.
Marius Pharmaceuticals Tech Stack
A closer look at the technologies used by Marius Pharmaceuticals
See more technologies
Most Recent Scoops
Event
Person-Based
Events, Podcast
Person-Based
Event
Person-Based
Shalin Shah, Chief Executive Officer, appeared on a podcast called "The Human Upgrade with Dave Asprey" on 05/09/2025. Topics discussed include Testosterone, longevity, health, therapy, women.
Events, Podcast
Person-Based
Person-Based
Marius Pharmaceuticals News & Media
Marius Pharmaceuticals Welcomes Department of Defense's New Testosterone Screening Initiative for U.S. Service Members
RALEIGH, N.C., July 16, 2026 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc., a specialty pharmaceutical company advancing the science of testosterone therapy and hormone health, today welcomed Defense Secretary Pete Hegseth's announcement that the Department of Defense will begin annually screening service members age 30 and older for testosterone deficiency, with optional screening available to younger troops. The program, which will be incorporated into the military's existing periodic healtMarius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health
The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic modernization of how testosterone therapy is prescribed, bringing labeling in step with a decade of new clinical evidence. Marius CEO Shalin Shah, an invited speaker at the agency’s expert panel on the therapy, helped advance the earlier change.New Research from Marius Pharmaceuticals Reveals Major Men's Health Awareness Gap: 65% Have Never Had Their Testosterone Levels Tested
National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily life National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily lifeMarius Pharmaceuticals Announces Key Leadership Expansion and Launch of Marius AI, Positioning the Company as the First AI-Native Pharmaceutical Company
Industry Veterans Join Growing Team as Marius Accelerates Its Mission to Transform Men's Health Industry Veterans Join Growing Team as Marius Accelerates Its Mission to Transform Men's Health
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Marius Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies aimed at improving metabolic vitality and well-being. The company focuses on addressing testosterone deficiency with innovative solutions for both men and women, particularly through their proprietary oral testosterone therapy, KYZATREX. This pres... Read More
